Trade GoodRx Holdings, Inc. - GDRX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 4.96 |
Open* | 4.91 |
1-Year Change* | -78.09% |
Day's Range* | 4.91 - 5.36 |
52 wk Range | 3.82-30.89 |
Average Volume (10 days) | 1.71M |
Average Volume (3 months) | 37.53M |
Market Cap | 2.11B |
P/E Ratio | -100.00K |
Shares Outstanding | 709.92M |
Revenue | 795.70M |
EPS | -0.17 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Feb 27, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 27, 2023 | 5.28 | 0.39 | 7.98% | 4.89 | 5.36 | 4.85 |
Jan 26, 2023 | 4.96 | 0.09 | 1.85% | 4.87 | 4.99 | 4.78 |
Jan 25, 2023 | 4.79 | -0.19 | -3.82% | 4.98 | 5.04 | 4.65 |
Jan 24, 2023 | 5.16 | -0.31 | -5.67% | 5.47 | 5.60 | 5.14 |
Jan 23, 2023 | 5.60 | 0.43 | 8.32% | 5.17 | 5.68 | 5.17 |
Jan 20, 2023 | 5.27 | 0.06 | 1.15% | 5.21 | 5.32 | 5.08 |
Jan 19, 2023 | 5.15 | 0.21 | 4.25% | 4.94 | 5.19 | 4.91 |
Jan 18, 2023 | 5.18 | -0.13 | -2.45% | 5.31 | 5.47 | 5.18 |
Jan 17, 2023 | 5.33 | 0.19 | 3.70% | 5.14 | 5.45 | 5.03 |
Jan 13, 2023 | 5.25 | 0.18 | 3.55% | 5.07 | 5.26 | 4.93 |
Jan 12, 2023 | 5.17 | 0.00 | 0.00% | 5.17 | 5.21 | 5.02 |
Jan 11, 2023 | 5.16 | 0.06 | 1.18% | 5.10 | 5.22 | 5.01 |
Jan 10, 2023 | 5.08 | 0.19 | 3.89% | 4.89 | 5.10 | 4.87 |
Jan 9, 2023 | 4.94 | 0.10 | 2.07% | 4.84 | 5.06 | 4.84 |
Jan 6, 2023 | 4.82 | 0.13 | 2.77% | 4.69 | 4.90 | 4.50 |
Jan 5, 2023 | 4.73 | 0.11 | 2.38% | 4.62 | 4.77 | 4.60 |
Jan 4, 2023 | 4.82 | 0.10 | 2.12% | 4.72 | 4.92 | 4.59 |
Jan 3, 2023 | 4.69 | 0.04 | 0.86% | 4.65 | 4.97 | 4.60 |
Dec 30, 2022 | 4.63 | 0.11 | 2.43% | 4.52 | 4.63 | 4.46 |
Dec 29, 2022 | 4.70 | 0.44 | 10.33% | 4.26 | 4.73 | 4.26 |
GoodRx Holdings, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 99.377 | 157.24 | 249.522 | 388.224 | 550.7 | 745.424 |
Revenue | 99.377 | 157.24 | 249.522 | 388.224 | 550.7 | 745.424 |
Cost of Revenue, Total | 1.23 | 3.075 | 6.035 | 14.016 | 29.587 | 46.716 |
Gross Profit | 98.147 | 154.165 | 243.487 | 374.208 | 521.113 | 698.708 |
Total Operating Expense | 80.602 | 110.596 | 175.128 | 253.425 | 826.419 | 732.018 |
Selling/General/Admin. Expenses, Total | 64.541 | 83.26 | 112.536 | 191.659 | 715.586 | 524.903 |
Research & Development | 5.742 | 11.501 | 43.894 | 29.3 | 61.816 | 125.86 |
Depreciation / Amortization | 9.089 | 9.099 | 9.806 | 13.573 | 18.43 | 34.539 |
Operating Income | 18.775 | 46.644 | 74.394 | 134.799 | -275.719 | 13.406 |
Interest Income (Expense), Net Non-Operating | -3.52 | -6.946 | -22.039 | -48.854 | -27.753 | -23.583 |
Other, Net | -0.154 | 0.005 | -0.007 | -2.967 | 0.022 | 0 |
Net Income Before Taxes | 15.101 | 39.703 | 52.348 | 82.978 | -303.45 | -10.177 |
Net Income After Taxes | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Net Income Before Extra. Items | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Net Income | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Income Available to Common Excl. Extra. Items | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Income Available to Common Incl. Extra. Items | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Diluted Net Income | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Diluted Weighted Average Shares | 383.223 | 383.223 | 383.223 | 383.223 | 274.696 | 409.981 |
Diluted EPS Excluding Extraordinary Items | 0.02326 | 0.07508 | 0.11428 | 0.17235 | -1.0689 | -0.0616 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.02326 | 0.082 | 0.12051 | 0.18248 | -1.06654 | -0.03893 |
Unusual Expense (Income) | 3.661 | 2.857 | 4.877 | 1 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 160.431 | 176.635 | 195.102 | 213.256 | 203.329 |
Revenue | 160.431 | 176.635 | 195.102 | 213.256 | 203.329 |
Cost of Revenue, Total | 10.428 | 11.09 | 11.271 | 13.927 | 12.28 |
Gross Profit | 150.003 | 165.545 | 183.831 | 199.329 | 191.049 |
Total Operating Expense | 165.429 | 176.986 | 188.103 | 201.5 | 183.568 |
Selling/General/Admin. Expenses, Total | 123.48 | 127.96 | 131.598 | 141.865 | 124.873 |
Research & Development | 26.16 | 29.567 | 35.073 | 35.06 | 35.042 |
Depreciation / Amortization | 5.361 | 8.369 | 10.161 | 10.648 | 11.373 |
Operating Income | -4.998 | -0.351 | 6.999 | 11.756 | 19.761 |
Interest Income (Expense), Net Non-Operating | -5.889 | -5.893 | -5.915 | -5.886 | -5.817 |
Net Income Before Taxes | -10.887 | -6.244 | 1.084 | 5.87 | 13.944 |
Net Income After Taxes | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Net Income Before Extra. Items | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Net Income | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Income Available to Common Excl. Extra. Items | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Income Available to Common Incl. Extra. Items | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Diluted Net Income | 1.668 | 31.061 | -18.069 | -39.914 | 12.8213 |
Diluted Weighted Average Shares | 429.577 | 428.867 | 411.223 | 414.068 | 427.378 |
Diluted EPS Excluding Extraordinary Items | 0.00388 | 0.07243 | -0.04394 | -0.09639 | 0.03 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.00849 | 0.07819 | -0.0402 | -0.08841 | 0.03471 |
Other, Net | 0 | 0 | 0 | ||
Unusual Expense (Income) | 0 | ||||
Dilution Adjustment | 0.52834 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 73.071 | 86.582 | 1086.37 | 1088.83 | ||
Cash and Short Term Investments | 34.6 | 26.05 | 968.691 | 941.109 | ||
Cash | 34.6 | 26.05 | 968.691 | 941.109 | ||
Total Receivables, Net | 35.023 | 48.129 | 97.293 | 126.411 | ||
Accounts Receivable - Trade, Net | 33.359 | 48.129 | 68.729 | 118.08 | ||
Prepaid Expenses | 3.448 | 12.403 | 17.484 | 21.307 | ||
Total Assets | 314.791 | 386.796 | 1470.11 | 1607.62 | ||
Property/Plant/Equipment, Total - Net | 0.988 | 34.175 | 50.769 | 49.317 | ||
Property/Plant/Equipment, Total - Gross | 1.542 | 35.442 | 52.899 | 55.146 | ||
Accumulated Depreciation, Total | -0.554 | -1.267 | -2.13 | -5.829 | ||
Goodwill, Net | 220.42 | 236.225 | 261.116 | 329.696 | ||
Intangibles, Net | 18.27 | 26.445 | 56.719 | 133.778 | ||
Other Long Term Assets, Total | 2.042 | 3.369 | 15.142 | 6.007 | ||
Total Current Liabilities | 16.62 | 33.373 | 59.551 | 81.113 | ||
Accounts Payable | 7.2 | 7.851 | 10.291 | 17.501 | ||
Accrued Expenses | 3.732 | 13.691 | 35.379 | 49.714 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | ||
Current Port. of LT Debt/Capital Leases | 5.43 | 7.029 | 7.029 | 7.029 | ||
Other Current Liabilities, Total | 0.258 | 4.802 | 6.852 | 6.869 | ||
Total Liabilities | 740.209 | 737.369 | 758.755 | 775.945 | ||
Total Long Term Debt | 716.806 | 663.893 | 659.888 | 655.858 | ||
Long Term Debt | 716.806 | 663.893 | 659.888 | 655.858 | ||
Deferred Income Tax | 3.456 | 0.244 | ||||
Other Liabilities, Total | 3.327 | 40.103 | 39.316 | 38.73 | ||
Total Equity | -425.418 | -350.573 | 711.359 | 831.68 | ||
Redeemable Preferred Stock | 737.009 | 737.009 | 0 | 0 | ||
Common Stock | 0.451 | 0.46 | 0.039 | 0.04 | ||
Retained Earnings (Accumulated Deficit) | -1162.88 | -1096.83 | -1390.45 | -1415.71 | ||
Total Liabilities & Shareholders’ Equity | 314.791 | 386.796 | 1470.11 | 1607.62 | ||
Total Common Shares Outstanding | 383.223 | 383.223 | 391.66 | 398.681 | ||
Additional Paid-In Capital | 8.788 | 2101.77 | 2247.35 | |||
Other Current Assets, Total | 2.9 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1123.38 | 1075.75 | 1051.54 | 1088.83 | 994.723 |
Cash and Short Term Investments | 990.463 | 894.703 | 912.023 | 941.109 | 845.427 |
Cash | 990.463 | 894.703 | 912.023 | 941.109 | 845.427 |
Total Receivables, Net | 115.791 | 166.801 | 126.38 | 126.411 | 129.107 |
Accounts Receivable - Trade, Net | 74.399 | 87.004 | 98.511 | 118.08 | 123.281 |
Prepaid Expenses | 14.226 | 14.246 | 13.137 | 21.307 | 20.189 |
Other Current Assets, Total | 2.9 | 0 | 0 | 0 | |
Total Assets | 1510.97 | 1586.93 | 1614.36 | 1607.62 | 1538.33 |
Property/Plant/Equipment, Total - Net | 50.576 | 49.007 | 47.806 | 49.317 | 49.542 |
Goodwill, Net | 261.116 | 320.196 | 329.696 | 329.696 | 334.642 |
Intangibles, Net | 60.387 | 126.776 | 133.331 | 133.778 | 138.495 |
Other Long Term Assets, Total | 15.515 | 15.2 | 51.992 | 6.007 | 20.926 |
Total Current Liabilities | 63.049 | 65.491 | 72.681 | 81.113 | 59.364 |
Accounts Payable | 15.101 | 18.378 | 17.279 | 17.501 | 12.82 |
Accrued Expenses | 32.115 | 31.185 | 40.163 | 49.714 | 29.196 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 7.029 | 7.029 |
Other Current Liabilities, Total | 8.804 | 8.899 | 8.21 | 6.869 | 10.319 |
Total Liabilities | 761.915 | 762.535 | 767.969 | 775.945 | 751.821 |
Total Long Term Debt | 658.883 | 657.877 | 656.868 | 655.858 | 654.845 |
Long Term Debt | 658.883 | 657.877 | 656.868 | 655.858 | 654.845 |
Other Liabilities, Total | 39.983 | 39.167 | 38.42 | 38.73 | 37.215 |
Total Equity | 749.059 | 824.394 | 846.396 | 831.68 | 786.507 |
Common Stock | 0.039 | 0.039 | 0.039 | 0.04 | 0.04 |
Additional Paid-In Capital | 2137.8 | 2182.08 | 2222.15 | 2247.35 | 2189.88 |
Retained Earnings (Accumulated Deficit) | -1388.79 | -1357.72 | -1375.79 | -1415.71 | -1403.41 |
Total Liabilities & Shareholders’ Equity | 1510.97 | 1586.93 | 1614.36 | 1607.62 | 1538.33 |
Total Common Shares Outstanding | 392.457 | 395.393 | 398.681 | 398.681 | 396.132 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Deferred Income Tax | 0.244 | 0.397 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 43.793 | 66.048 | -293.623 | -25.254 | ||
Cash From Operating Activities | 45.253 | 83.286 | 131.341 | 178.779 | ||
Cash From Operating Activities | 9.806 | 13.573 | 18.43 | 34.539 | ||
Deferred Taxes | -2.433 | -5.674 | -10.91 | 12.851 | ||
Non-Cash Items | 5.858 | 14.155 | 449.903 | 168.439 | ||
Cash Taxes Paid | 11.7 | 19.4 | 29.228 | 18.105 | ||
Cash Interest Paid | 18.658 | 48.443 | 24.517 | 20.198 | ||
Changes in Working Capital | -11.771 | -4.816 | -32.459 | -11.796 | ||
Cash From Investing Activities | -3.458 | -37.055 | -91.617 | -178.733 | ||
Capital Expenditures | -3.458 | -5.749 | -35.824 | -34.457 | ||
Other Investing Cash Flow Items, Total | 0 | -31.306 | -55.793 | -144.276 | ||
Cash From Financing Activities | -24.734 | -54.781 | 905.817 | -30.528 | ||
Financing Cash Flow Items | -1371.97 | -2.214 | 15.043 | -58.52 | ||
Issuance (Retirement) of Stock, Net | 740.358 | 4.665 | 897.803 | 35.021 | ||
Issuance (Retirement) of Debt, Net | 606.876 | -57.232 | -7.029 | -7.029 | ||
Net Change in Cash | 17.061 | -8.55 | 945.541 | -30.482 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1.668 | 32.729 | 14.66 | -25.254 | 12.293 |
Cash From Operating Activities | 45.485 | 80.411 | 128.969 | 178.779 | 30.12 |
Cash From Operating Activities | 5.361 | 13.73 | 23.891 | 34.539 | 11.373 |
Deferred Taxes | -0.227 | -0.364 | -33.217 | 12.851 | -0.394 |
Non-Cash Items | 48.261 | 91.5 | 133.649 | 168.439 | 31.732 |
Changes in Working Capital | -9.578 | -57.184 | -10.014 | -11.796 | -24.884 |
Cash From Investing Activities | -9.695 | -142.416 | -169.474 | -178.733 | -34.401 |
Capital Expenditures | -9.695 | -16.688 | -25.198 | -34.457 | -12.418 |
Cash From Financing Activities | -14.018 | -14.883 | -19.063 | -30.528 | -91.401 |
Financing Cash Flow Items | -14.633 | -26.849 | -43.506 | -58.52 | -9.561 |
Issuance (Retirement) of Stock, Net | 2.372 | 15.481 | 29.715 | 35.021 | -80.082 |
Issuance (Retirement) of Debt, Net | -1.757 | -3.515 | -5.272 | -7.029 | -1.758 |
Net Change in Cash | 21.772 | -76.888 | -59.568 | -30.482 | -95.682 |
Other Investing Cash Flow Items, Total | -125.728 | -144.276 | -144.276 | -21.983 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4792 | 7816360 | 739017 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 5.3318 | 4396531 | 2279989 | 2022-12-13 | HIGH |
Light Street Capital Management, LLC | Investment Advisor/Hedge Fund | 5.0836 | 4191872 | -437404 | 2022-09-30 | HIGH |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 4.3934 | 3622709 | 55218 | 2022-09-30 | HIGH |
Silver Lake Partners | Private Equity | 4.2837 | 3532276 | 0 | 2022-09-30 | LOW |
Slutsky (Andrew) | Individual Investor | 3.887 | 3205126 | 31512 | 2022-04-19 | LOW |
Two Sigma Investments, LP | Hedge Fund | 3.6134 | 2979556 | -63560 | 2022-09-30 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 2.6942 | 2221622 | -1024000 | 2022-09-30 | HIGH |
Perot Investments | Investment Advisor/Hedge Fund | 2.6238 | 2163566 | 359632 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0657 | 1703329 | 234672 | 2022-09-30 | LOW |
Technology Crossover Ventures | Venture Capital | 2.0053 | 1653566 | 0 | 2022-09-30 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.8559 | 1530333 | 1530333 | 2022-09-30 | MED |
Voloridge Investment Management, LLC | Investment Advisor/Hedge Fund | 1.4858 | 1225186 | 806904 | 2022-09-30 | HIGH |
Norwood Investment Partners, LP | Investment Advisor | 1.4808 | 1221000 | 1194742 | 2022-09-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.385 | 1142009 | 594803 | 2022-09-30 | MED |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.1537 | 951343 | -137008 | 2022-09-30 | MED |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.9515 | 784568 | 260599 | 2022-09-30 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.8914 | 735028 | 352110 | 2022-09-30 | LOW |
Goldman Sachs & Company, Inc. | Research Firm | 0.8566 | 706359 | 254727 | 2022-09-30 | MED |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8553 | 705300 | 705300 | 2021-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GoodRx Holdings, Inc. Company profile
GoodRx is a startup company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States. The website gets about fourteen million visitors a month. As of February 25, 2020, "millions of people" had downloaded the GoodRx app.Industry: | Online Services (NEC) |
2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US
Income Statement
- Annual
- Quarterly
News

FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis
USD, GBP/USD, EUR/USD forecasts for the week ahead.
16:33, 27 January 2023
WTI, Gold, Silver – commodities weekly forecast for the week ahead
Strength to strength in the commodity space, however, topside exhaustion begins to creep in
13:53, 27 January 2023
S&P 500, Nasdaq, DAX 40, Hang Seng technical update
Can the S&P 500 hold above its 2022 descending trend line?
12:44, 26 January 2023
Amazon Q4 earnings: online retailer to feel the pinch of higher costs and slowing consumer spending
AMZN Q4 earnings preview and technical analysis
09:59, 25 January 2023
Canadian Dollar Forecast: Bank of Canada Heading Towards a Final Rate Hike
Bank of Canada expected to hike 25bps at its upcoming meeting. Focus on whether the BoC announces a pause going forward.
15:49, 24 January 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com